TY - JOUR
AU - Karlsen, Tom H.
AU - Sheron, Nick
AU - Zelber-Sagi, Shira
AU - Carrieri, Patrizia
AU - Dusheiko, Geoffrey
AU - Bugianesi, Elisabetta
AU - Pryke, Rachel
AU - Hutchinson, Sharon J.
AU - Sangro, Bruno
AU - Martin, Natasha K.
AU - Cecchini, Michele
AU - Dirac, Mae A.
AU - Belloni, Annalisa
AU - Serra-Burriel, Miquel
AU - Ponsioen, Cyriel Y.
AU - Sheena, Brittney
AU - Lerouge, Alienor
AU - Devaux, Marion
AU - Scott, Nick
AU - Hellard, Margaret
AU - Verkade, Henkjan J.
AU - Sturm, Ekkehard
AU - Marchesini, Giulio
AU - Yki-Järvinen, Hannele
AU - Bryne, Chris D.
AU - Targher, Giovanni
AU - Tur-Sinai, Aviad
AU - Barrett, Damon
AU - Ninburg, Michael
AU - Reic, Tatjana
AU - Taylor, Alison H.M.
AU - Rhodes, Tim
AU - Treloar, Carla
AU - Petersen, Claus
AU - Schramm, Christoph
AU - Flisiak, Robert
AU - Simonova, Marieta Y.
AU - Pares, Albert
AU - Johnson, Philip
AU - Cucchetti, Alessandro
AU - Graupera, Isabel
AU - Lionis, Christos
AU - Pose, Elisa
AU - Fabrellas, Núria
AU - Ma, Ann T.
AU - Mendive, Juan M.
AU - Mazzaferro, Vincenzo
AU - Rutter, Harry
AU - Cortez-Pinto, Helena
AU - Kelly, Deirdre
AU - Burton, Robyn
AU - Lazarus, Jeffrey V.
AU - Ginès, Pere
AU - Buti, Maria
AU - Newsome, Philip N.
AU - Burra, Patrizia
AU - Manns, Michael P.
PY - 2022
DA - January
TI - The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality
JO - The Lancet
EP - 116
VL - 399 
IS - 10319 
DO - https://doi.org/10.1016/S0140-6736(21)01701-3
AB - Liver diseases have become a major health threat across Europe, and the face of European hepatology is changing due to the cure of viral hepatitis C and the control of chronic viral hepatitis B, the increasingly widespread unhealthy use of alcohol, the epidemic of obesity, and undiagnosed or untreated liver disease in migrant populations. Consequently, Europe is facing a looming syndemic, in which socioeconomic and health inequities combine to adversely affect liver disease prevalence, outcomes, and opportunities to receive care. In addition, the COVID-19 pandemic has magnified pre-existing challenges to uniform implementation of policies and equity of access to care in Europe, arising from national borders and the cultural and historical heterogeneity of European societies. In following up on work from the Lancet Commission on liver disease in the UK and epidemiological studies led by the European Association for the Study of the Liver (EASL), our multidisciplinary Commission, comprising a wide range of public health, medical, and nursing specialty groups, along with patient representatives, set out to provide a snapshot of the European landscape on liver diseases and to propose a framework for the principal actions required to improve liver health in Europe. We believe that a joint European process of thinking, and construction of uniform policies and action, implementation, and evaluation can serve as a powerful mechanism to improve liver care in Europe and set the way for similar changes globally.
PB - Elsevier
UR - https://researchonline.gcu.ac.uk/en/publications/e6e5b72e-10dc-419b-85f1-4a08ff9a44dc
KW - Coronavirus (COVID-19)
ER